ALVIN Fundamental Analysis - VINPAI SAS

Fundamental Rating

Taking everything into account, ALVIN scores 2 out of 10 in our fundamental rating. ALVIN was compared to 68 industry peers in the Chemicals industry. Both the profitability and financial health of ALVIN have multiple concerns. ALVIN is valued quite expensive, but it does show an excellent growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALVIN has reported negative net income.

In the past 5 years ALVIN always reported negative net income.

In the past 5 years ALVIN always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -24.00%, ALVIN is doing worse than 91.18% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-24%
ROE	N/A
ROIC	N/A

ROA(3y)-27.77%

ROA(5y)-20.34%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of ALVIN (7.26%) is worse than 89.71% of its industry peers.

ALVIN's Gross Margin has declined in the last couple of years.

ALVIN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	7.26%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-30.19%

GM growth 5Y-20.18%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALVIN does not have a ROIC to compare to the WACC, probably because it is not profitable.

ALVIN has more shares outstanding than it did 1 year ago.

ALVIN has more shares outstanding than it did 5 years ago.

The debt/assets ratio for ALVIN is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -0.29, we must say that ALVIN is in the distress zone and has some risk of bankruptcy.

ALVIN has a worse Altman-Z score (-0.29) than 89.71% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-0.29

ROIC/WACCN/A

WACC6.79%

2.3 Liquidity

ALVIN has a Current Ratio of 0.46. This is a bad value and indicates that ALVIN is not financially healthy enough and could expect problems in meeting its short term obligations.

The Current ratio of ALVIN (0.46) is worse than 95.59% of its industry peers.

ALVIN has a Quick Ratio of 0.46. This is a bad value and indicates that ALVIN is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 0.33, ALVIN is doing worse than 95.59% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	0.46
Quick Ratio	0.33

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALVIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.42%, which is quite impressive.

The Revenue has grown by 8.00% in the past year. This is quite good.

Measured over the past years, ALVIN shows a very strong growth in Revenue. The Revenue has been growing by 65.39% on average per year.

EPS 1Y (TTM)32.42%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%21.05%

Revenue 1Y (TTM)8%

Revenue growth 3Y21.3%

Revenue growth 5Y65.39%

Sales Q2Q%3.73%

3.2 Future

Based on estimates for the next years, ALVIN will show a very strong growth in Earnings Per Share. The EPS will grow by 97.18% on average per year.

Based on estimates for the next years, ALVIN will show a very strong growth in Revenue. The Revenue will grow by 26.45% on average per year.

EPS Next Y350%

EPS Next 2Y141.52%

EPS Next 3Y97.18%

EPS Next 5YN/A

Revenue Next Year33.7%

Revenue Next 2Y31.88%

Revenue Next 3Y26.45%

Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALVIN. In the last year negative earnings were reported.

A Price/Forward Earnings ratio of 15.11 indicates a correct valuation of ALVIN.

Compared to the rest of the industry, the Price/Forward Earnings ratio of ALVIN indicates a somewhat cheap valuation: ALVIN is cheaper than 64.71% of the companies listed in the same industry.

ALVIN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.23.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	15.11

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as ALVIN's earnings are expected to grow with 97.18% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y141.52%

EPS Next 3Y97.18%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALVIN does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

VINPAI SAS

EPA:ALVIN (1/2/2026, 7:00:00 PM)

3.58

0 (0%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners46.75%

Ins Owner ChangeN/A

Market Cap12.39M

Revenue(TTM)9.33M

Net Income(TTM)-2.64M

Analysts40

Price Target4.59 (28.21%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly Dividend0

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	15.11
P/S	1.33
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-0.79

EYN/A

EPS(NY)0.24

Fwd EY6.62%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS2.7

BVpS-0.29

TBVpS-1.33

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-24%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	7.26%
FCFM	N/A

ROA(3y)-27.77%

ROA(5y)-20.34%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-30.19%

GM growth 5Y-20.18%

F-ScoreN/A

Asset Turnover0.85

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.46
Quick Ratio	0.33
Altman-Z	-0.29

F-ScoreN/A

WACC6.79%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)32.42%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%21.05%

EPS Next Y350%

EPS Next 2Y141.52%

EPS Next 3Y97.18%

EPS Next 5YN/A

Revenue 1Y (TTM)8%

Revenue growth 3Y21.3%

Revenue growth 5Y65.39%

Sales Q2Q%3.73%

Revenue Next Year33.7%

Revenue Next 2Y31.88%

Revenue Next 3Y26.45%

Revenue Next 5YN/A

EBIT growth 1Y-1.58%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year91.79%

EBIT Next 3Y38.5%

EBIT Next 5YN/A

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

VINPAI SAS / ALVIN.PA FAQ

What is the ChartMill fundamental rating of VINPAI SAS (ALVIN.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALVIN.PA.

What is the valuation status of VINPAI SAS (ALVIN.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to VINPAI SAS (ALVIN.PA). This can be considered as Overvalued.

What is the profitability of ALVIN stock?

VINPAI SAS (ALVIN.PA) has a profitability rating of 0 / 10.

What is the financial health of VINPAI SAS (ALVIN.PA) stock?

The financial health rating of VINPAI SAS (ALVIN.PA) is 0 / 10.

VINPAI SAS (ALVIN.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

VINPAI SAS / ALVIN.PA FAQ

What is the ChartMill fundamental rating of VINPAI SAS (ALVIN.PA) stock?

What is the valuation status of VINPAI SAS (ALVIN.PA) stock?

What is the profitability of ALVIN stock?

What is the financial health of VINPAI SAS (ALVIN.PA) stock?